The goal of this study is to better understand the effects of the recreational use of Instagram on female figure skaters and ballet dancers.

The purpose of this study is to learn more about the number of female collegiate athletes who fall in the "at-risk"category for developing low energy availability. Low energy availability can cause an increased risk of developing a musculoskeletal injury. If we can learn how common the condition is, then we can work to develop better strategies for screening purposes.

Are you a non-drinker? Are you physically active or do you tend to sit a lot? If you're interested in learning about how alcohol use and physical activity may affect your health, you may be able to participate in our research study that includes two in-person study visits and a 21-day monitoring period. Compensation provided.

Do you and your romantic partner want to cut back on substance use? Are you wanting to spend your time together in more meaningful ways? You may be able to take part in a research study testing a new couple's therapy treatment for substance use. Benefits include 3 months of couple's therapy at no cost.

Are you a young woman who had early puberty? We are interviewing young adult women who had early puberty and their mothers to understand the experiences and needs of girls who have early puberty. Mothers and daughters will be interviewed separately. Compensation will be provided.

Have you recently been diagnosed with breast cancer but have not yet started treatment (other than surgery)? You may be able to take part in the UNC CogMAP study. In this study, we want to learn more about cognitive and brain function before and after cancer treatment. This will help us to better understand risk factors for experiencing cognitive difficulties during and after treatment.

Are you pregnant or did you recently have a baby? Do you have Medicaid insurance? If so, you may be able to participate in a research study to help find ways for more pregnant people to get the dental care they need. Compensation provided.

This is a Phase 1b/2, multicenter, open-label, basket study evaluating ACR-368, an adenosine triphosphate-competitive selective inhibitor of checkpoint kinase (CHK)1 and CHK2, as monotherapy and in combination with ultralow-dose gemcitabine (ULDG), in the treatment of subjects with histologically confirmed, locally advanced or metastatic, recurrent platinum-resistant high-grade ovarian or endometrial adenocarcinoma, or platinum-resistant urothelial carcinoma (hereafter referred to as ovarian, endometrial, and urothelial, respectively).

Did you know that over 250 million persons are affected by Osteoarthritis? It is the leading cause of disability among adults and has no cure. Prevention of OA is preferable to treatment and females are affected at nearly twice the rate as males. If you are a female, at least 50 years of age, overweight, with no or occasional knee pain, you may be able to participate in a research study to find out if a diet and exercise program or a health education program prevent knee OA.

Do you have grade 1 or 2 edometrioid endometrial cancer? You may be able to take part in a study to learn more about and test a new drug.